CN109195945A - 稠合三环γ-氨基酸衍生物及其制备方法和在医药上的应用 - Google Patents

稠合三环γ-氨基酸衍生物及其制备方法和在医药上的应用 Download PDF

Info

Publication number
CN109195945A
CN109195945A CN201780033351.4A CN201780033351A CN109195945A CN 109195945 A CN109195945 A CN 109195945A CN 201780033351 A CN201780033351 A CN 201780033351A CN 109195945 A CN109195945 A CN 109195945A
Authority
CN
China
Prior art keywords
alkyl
yuan
compound
amino
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201780033351.4A
Other languages
English (en)
Other versions
CN109195945B (zh
Inventor
李瑶
石宗军
徐波
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sichuan Haisco Pharmaceutical Co Ltd
Original Assignee
Sichuan Haisco Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sichuan Haisco Pharmaceutical Co Ltd filed Critical Sichuan Haisco Pharmaceutical Co Ltd
Publication of CN109195945A publication Critical patent/CN109195945A/zh
Application granted granted Critical
Publication of CN109195945B publication Critical patent/CN109195945B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/28—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/46—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C229/50—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups and carboxyl groups bound to carbon atoms being part of the same condensed ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/29—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton of non-condensed six-membered aromatic rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

公开了一种稠合三环γ‑氨基酸衍生物及其在医药上的应用，具体而言涉及如通式(I)所示的稠合环γ‑氨基酸衍生物，或者其立体异构体、溶剂化物、代谢产物、前药、药学上可接受的盐或共晶，包含其的药物组合物以及化合物或组合物在镇痛领域的用途，其中，通式(I)中各取代基的定义与说明书的定义相同

Description

PCT国内申请，说明书已公开。

Claims (12)

  1. PCT国内申请，权利要求书已公开。
CN201780033351.4A 2016-09-14 2017-09-12 稠合三环γ-氨基酸衍生物及其制备方法和在医药上的应用 Active CN109195945B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN2016108256119 2016-09-14
CN201610825611 2016-09-14
PCT/CN2017/101364 WO2018050046A1 (zh) 2016-09-14 2017-09-12 稠合三环γ-氨基酸衍生物及其制备方法和在医药上的应用

Publications (2)

Publication Number Publication Date
CN109195945A true CN109195945A (zh) 2019-01-11
CN109195945B CN109195945B (zh) 2022-02-25

Family

ID=61619859

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201780033351.4A Active CN109195945B (zh) 2016-09-14 2017-09-12 稠合三环γ-氨基酸衍生物及其制备方法和在医药上的应用

Country Status (15)

Country Link
US (1) US10654794B2 (zh)
EP (1) EP3527552B1 (zh)
JP (1) JP7001679B2 (zh)
KR (1) KR102335089B1 (zh)
CN (1) CN109195945B (zh)
AU (1) AU2017325913B2 (zh)
CA (1) CA3035121C (zh)
EA (1) EA036525B1 (zh)
ES (1) ES2939260T3 (zh)
MX (1) MX2019002915A (zh)
MY (1) MY196788A (zh)
PT (1) PT3527552T (zh)
TW (1) TWI662015B (zh)
WO (1) WO2018050046A1 (zh)
ZA (1) ZA201901861B (zh)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111517939A (zh) * 2019-02-01 2020-08-11 四川海思科制药有限公司 一种稠合三环衍生物制备方法及中间体
CN111517932A (zh) * 2019-02-01 2020-08-11 四川海思科制药有限公司 一种稠合三环衍生物制备方法及中间体

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202019871A (zh) * 2018-07-12 2020-06-01 大陸商四川海思科製藥有限公司 稠合三環γ-胺基酸衍生物鹽類之晶型、製備方法及其用途
JP7222063B2 (ja) * 2018-07-12 2023-02-14 四川海思科制▲薬▼有限公司 縮合三環性γ－アミノ酸誘導体の組成物及びその調製
WO2020029762A1 (zh) * 2018-08-09 2020-02-13 四川海思科制药有限公司 稠合三环γ-氨基酸衍生物的制备方法及中间体
WO2020155953A1 (zh) * 2019-01-30 2020-08-06 四川海思科制药有限公司 一种稠合三环氘代衍生物及其组合物和应用
CN113348164B (zh) * 2019-02-01 2023-08-29 四川海思科制药有限公司 一种稠合三环衍生物的制备方法及中间体
CN111517930B (zh) * 2019-02-01 2023-03-24 四川海思科制药有限公司 一种稠合三环衍生物制备方法及中间体
CN114402198A (zh) * 2019-09-03 2022-04-26 四川海思科制药有限公司 2-((1s,2s,3r,6s,8s)-2-(氨甲基)三环[4.2.1.03,8]壬烷-2-基)乙酸苯磺酸盐或其组合物杂质检测方法
EP4183771A4 (en) 2020-07-20 2024-04-24 Sichuan Haisco Pharmaceutical Co Ltd SUSTAINED RELEASE PHARMACEUTICAL FORMULATION OF A CONDENSED TRICYCLIC T-AMINO ACID DERIVATIVE AND METHOD OF MANUFACTURING THE SAME

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1720219A (zh) * 2001-04-19 2006-01-11 沃纳-兰伯特公司 稠合二环或三环氨基酸
CN101878193A (zh) * 2007-09-28 2010-11-03 第一三共株式会社 双环γ-氨基酸衍生物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100618743B1 (ko) * 2001-04-19 2006-08-31 워너-램버트 캄파니 엘엘씨 융합된 비사이클릭 또는 트리사이클릭 아미노산
JP5250363B2 (ja) 2008-09-26 2013-07-31 京セラドキュメントソリューションズ株式会社 テキスト入力システム及びテキスト入力プログラム
WO2010079668A1 (ja) 2009-01-08 2010-07-15 第一三共株式会社 オレフィン化合物
WO2010084798A1 (ja) * 2009-01-21 2010-07-29 第一三共株式会社 ３環性化合物
WO2017107907A1 (zh) 2015-12-25 2017-06-29 四川海思科制药有限公司 稠合环γ-氨基酸衍生物及其制备方法和在医药上的应用

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1720219A (zh) * 2001-04-19 2006-01-11 沃纳-兰伯特公司 稠合二环或三环氨基酸
CN101878193A (zh) * 2007-09-28 2010-11-03 第一三共株式会社 双环γ-氨基酸衍生物

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
MANFRED GEISEL等: "Die Cyclopropylcarbinyl-Cyclobutyl-Homoallyl-Umlagerung.I. Teit. Synthese von Tricyclo[3.2.1.02,7]octan-3-ol, endo- und exo-Tricyclo[3.2.1.03,6]octan-4-ol und exo-Bicyclo[3.2.l]-oct-2-en-7-ol", 《HELVETICA CHIMICA ACTA》 *
PETER YATES等: "DECOMPOSITION OF l-DIAZO-3-(2,2,3-TRIMETHYLCYCLOPENT-3-ENYL)PROPAN-2-ONE. A NOVEL SYNTHESIS AND REARRANGEMENT OF A TRICYCLO[3.2.1.03,6]0CTAN-4-ONE", 《TETRAHEDRON LETTERS》 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111517939A (zh) * 2019-02-01 2020-08-11 四川海思科制药有限公司 一种稠合三环衍生物制备方法及中间体
CN111517932A (zh) * 2019-02-01 2020-08-11 四川海思科制药有限公司 一种稠合三环衍生物制备方法及中间体
CN111517932B (zh) * 2019-02-01 2023-03-24 四川海思科制药有限公司 一种稠合三环衍生物制备方法及中间体
CN111517939B (zh) * 2019-02-01 2023-03-31 四川海思科制药有限公司 一种稠合三环衍生物制备方法及中间体

Also Published As

Publication number Publication date
EA201990455A1 (ru) 2019-09-30
EP3527552A1 (en) 2019-08-21
WO2018050046A1 (zh) 2018-03-22
EP3527552A4 (en) 2020-05-06
TW201811733A (zh) 2018-04-01
TWI662015B (zh) 2019-06-11
ZA201901861B (en) 2020-10-28
EP3527552B1 (en) 2022-11-30
US20190218172A1 (en) 2019-07-18
JP7001679B2 (ja) 2022-02-04
KR102335089B1 (ko) 2021-12-02
PT3527552T (pt) 2023-02-28
JP2019532925A (ja) 2019-11-14
MY196788A (en) 2023-05-03
AU2017325913A1 (en) 2019-05-02
CA3035121A1 (en) 2018-03-22
CN109195945B (zh) 2022-02-25
US10654794B2 (en) 2020-05-19
EA036525B1 (ru) 2020-11-19
ES2939260T3 (es) 2023-04-20
AU2017325913B2 (en) 2020-04-09
KR20190046892A (ko) 2019-05-07
CA3035121C (en) 2021-02-16
BR112019004860A2 (pt) 2019-06-11
MX2019002915A (es) 2019-07-18

Similar Documents

Publication Publication Date Title
CN109195945A (zh) 稠合三环γ-氨基酸衍生物及其制备方法和在医药上的应用
CN104718188B (zh) N-取代的苯甲酰胺类及其在治疗疼痛中的用途
ES2553968T3 (es) Moduladores del receptor NMDA y sus usos
CN106103452B (zh) 皮质抑素类似物及其合成和用途
JP7438956B2 (ja) ステロイド系誘導体モジュレーター、その製造方法及び応用
CN109415387A (zh) 精氨酸酶抑制剂及其治疗应用
CN107848952A (zh) 稠合三环γ‑氨基酸衍生物及其制备方法和在医药上的应用
NZ560368A (en) Methods and compostions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor
TW201609692A (zh) 取代吡唑及其用途
TW201726637A (zh) 對電位閘控鈉通道具選擇活性之羥基烷基胺－及羥基環烷基胺－取代之二胺－芳基磺胺化合物
CN106928080B (zh) 稠合环γ-氨基酸衍生物及其制备方法和在医药上的应用
CN105358559A (zh) 吡咯并吡啶或吡唑并吡啶衍生物
CN107848953A (zh) 稠合环γ‑氨基酸衍生物及其制备方法和在医药上的应用
WO2023274324A1 (zh) 一种含氮杂环化合物、其制备方法、中间体及应用
ITUB20152860A1 (it) Selezionata amide dell?acido ?-idrossibutirrico e suoi usi nel trattamento dell?abuso da alcool
WO2018170430A1 (en) Modulators of liver receptor homologue 1 (lrh-1) and uses
CA3206148A1 (en) Therapeutic modifiers of the reverse mode of atp synthase
EP2389350A1 (en) Methods for making valerenic acid derivatives and their use
WO2023051635A1 (zh) 一种稠环化合物、其制备方法及其应用
BR112019004860B1 (pt) Compostos, estereoisômeros, solvatos, pró-fármacos ou sais farmaceuticamente aceitáveis dos mesmos, composição farmacêutica contendo os mesmos, uso dos referidos compostos e composto intermediário
WO2024059608A1 (en) Deuterated neuroactive steroids
CN117957231A (zh) 一种稠环化合物、其制备方法及其应用
WO2023049295A1 (en) Deuterated positive nmda-modulating compounds and methods of use thereof
JPH11514383A (ja) 神経保護活性を有するチアモルヒナン

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1260138

Country of ref document: HK

GR01 Patent grant
GR01 Patent grant